Basic Amino Acids at the C‐Terminus of the Third Intracellular Loop Are Required for the Activation of Phospholipase C by Cholecystokinin‐B Receptors

Abstract: In common with other Gq protein‐coupled receptors, the third intracellular loop of the cholecystokinin‐B (CCK‐B) receptor contains three basic amino acids (K333/K334/R335) at the C‐terminal segment. To determine the importance of these conserved basic residues in Gq‐protein activation and stimulation of phospholipase C, these basic amino acids were mutated. Subsequently, the ability of resulting mutant receptors to activate phospholipase C was investigated by measuring inositol phosphate formation in COS‐7 cells and recording Ca2+‐activated Cl− currents from Xenopus oocytes. Site‐directed mutagenesis was performed to mutate the three basic amino acids, K333/K334/R335, to neutral amino acids, M333/T334/L335. When the resulting mutant CCK‐B receptors were expressed in COS‐7 cells and Xenopus oocytes, sulfated cholecystokinin octapeptide (CCK‐8) failed to induce inositol phosphate formation in COS‐7 cells and evoke Ca2+‐activated Cl− currents from oocytes. Each basic amino acid was also mutated (K333M, K334T, and R335L). All three single‐point mutations resulted in a significant reduction in CCK‐8‐induced inositol phosphate formation and CCK‐8‐activated Ca2+‐dependent Cl− currents. It is interesting that substituting the basic amino acids, K333/K334/R335, with three other basic residues, R333/R334/K335, did not change the maximal CCK‐8‐simulated inositol phosphate formation and the amplitude of CCK‐8‐evoked Ca2+‐dependent Cl− currents. Radioligand‐binding studies showed that the above‐mentioned mutations did not affect the affinity for CCK‐8 and receptor expression level in COS‐7 cells. These findings suggest that basic amino acids at the C‐terminus of the third cytoplasmic loop are required for the signal transduction by CCK‐B receptors.

[1]  M. Sukumar,et al.  G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide. , 1992, The Journal of biological chemistry.

[2]  S. Jayadev,et al.  Identification of a Domain in the Angiotensin II Type 1 Receptor Determining Gq Coupling by the Use of Receptor Chimeras (*) , 1995, The Journal of Biological Chemistry.

[3]  J. Rehfeld,et al.  Molecular Forms of Cholecystokinin in the Brain and the Relationship to Neuronal Gastrins a , 1985, Annals of the New York Academy of Sciences.

[4]  T. Katada,et al.  A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor , 1990, Cell.

[5]  Hung-Li Wang,et al.  Gαq/11 Mediates Cholecystokinin Activation of the Cationic Conductance in Rat Substantia Nigra Dopaminergic Neurons , 1996, Journal of neurochemistry.

[6]  M. Berridge,et al.  Inositol trisphosphate and calcium signaling. , 1988, Cold Spring Harbor symposia on quantitative biology.

[7]  R. Jensen,et al.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Neubig,et al.  Two peptides from the alpha 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. , 1991, The Journal of biological chemistry.

[9]  I. Nishimoto,et al.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.

[10]  A. Weerth,et al.  The brain and gastrointestinal cholecystokinin receptor family; structure and functional expression , 1992, Regulatory Peptides.

[11]  M. Caron,et al.  Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.

[12]  J. Wess,et al.  Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover , 1989, FEBS letters.

[13]  A. Trzeciak,et al.  Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  B. Roques,et al.  Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. , 1995, Molecular pharmacology.

[15]  Y. Kurosawa,et al.  A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. , 1991, Gene.

[16]  M. Goiny,et al.  On the Origin of Striatal Cholecystokinin Release: Studies with In Vivo Microdialysis , 1994, Journal of Neurochemistry.

[17]  L. F. Kolakowski,et al.  Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[19]  R. Chang,et al.  Ligands for Cholecystokinin A and Cholecystokinin B/Gastrin Receptors , 1991 .

[20]  S. Nakanishi,et al.  Molecular characterization of a functional cDNA for rat substance P receptor. , 1989, The Journal of biological chemistry.

[21]  E. Peralta,et al.  Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. , 1993, The EMBO journal.

[22]  B. Cullen Use of eukaryotic expression technology in the functional analysis of cloned genes. , 1987, Methods in enzymology.

[23]  J. Burnier,et al.  Regulation of Gi and G,, by Mastoparan, Related Amphiphilic Peptides, and Hydrophobic Amines , 1990 .

[24]  P. Godfrey Methods for the Analysis of Phosphoinositides and Inositol Phosphates , 1992 .

[25]  J. Wess,et al.  Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Kobilka,et al.  Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.

[27]  S. Yamagishi,et al.  Rat brain glutamate receptors activate chloride channels in Xenopus oocytes coupled by inositol trisphosphate and Ca2+. , 1989, The Journal of physiology.

[28]  Structure/function of muscarinic receptor coupling to G proteins: random-saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins , 1995 .

[29]  J. Rehfeld,et al.  Distribution of Cholecystokinin‐Like Peptides in the Human Brain , 1982, Journal of neurochemistry.

[30]  C. Fraser,et al.  Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. , 1996, Molecular pharmacology.

[31]  B. Costall,et al.  Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Lefkowitz,et al.  Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. , 1994, The Journal of biological chemistry.

[33]  R. Jensen,et al.  Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. , 1994, Molecular pharmacology.

[34]  J. Crawley Comparative Distribution of Cholecystokinin and Other Neuropeptides , 1985, Annals of the New York Academy of Sciences.

[35]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.